يعرض 21 - 30 نتائج من 1,763 نتيجة بحث عن '"Preoperative chemotherapy"', وقت الاستعلام: 0.87s تنقيح النتائج
  1. 21
  2. 22
    دورية أكاديمية
  3. 23
    دورية أكاديمية
  4. 24
    دورية أكاديمية
  5. 25
  6. 26
    دورية أكاديمية
  7. 27
    دورية أكاديمية
  8. 28
    دورية أكاديمية
  9. 29
    دورية أكاديمية

    المصدر: Research and Practical Medicine Journal; Том 10, № 1 (2023); 57-67 ; Research'n Practical Medicine Journal; Том 10, № 1 (2023); 57-67 ; 2410-1893 ; 10.17709/2410-1893-2023-10-1

    وصف الملف: application/pdf

    العلاقة: https://www.rpmj.ru/rpmj/article/view/860/538Test; https://www.rpmj.ru/rpmj/article/view/860/546Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/707Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/708Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/709Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/710Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/711Test; Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, et al.; BILCAP study group. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019 May;20(5):663–673. https://doi.org/10.1016/s1470Test‑2045(18)30915‑x Erratum in: Lancet Oncol. 2019 Apr 2.; Yadav S, Xie H, Bin‑Riaz I, Sharma P, Durani U, Goyal G, et al. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: propensity score matched analysis. Eur J Surg Oncol. 2019 Aug;45(8):1432–1438. https://doi.org/10.1016/j.ejso.2019.03.023Test; Tsilimigras DI, Sahara K, Wu L, Moris D, Bagante F, Guglielmi A, et al. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches. JAMA Surg. 2020 Sep 1;155(9):823–831. https://doi.org/10.1001/jamasurg.2020.1973Test; Rizzo A, Brandi G. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review. Cancer Treat Res Commun. 2021;27:100354. https://doi.org/10.1016/j.ctarc.2021.100354Test; Zhang XF, Beal EW, Bagante F, Chakedis J, Weiss M, Popescu I, et al. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. Br J Surg. 2018 Jun;105(7):848–856. https://doi.org/10.1002/bjs.10676Test; Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al.; ABC‑02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010 Apr 8;362(14):1273–1281. https://doi.org/10.1056/nejmoa0908721Test; Rizzo A, Brandi G. First‑line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC‑02 Trial: “And Yet It Moves!”. Cancer Treat Res Commun. 2021;27:100335. https://doi.org/10.1016/j.ctarc.2021.100335Test; Cho Y, Kim TH, Seong J. Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma. Strahlenther Onkol. 2017 Aug;193(8):620–629. https://doi.org/10.1007/s00066Test‑017‑1128‑7; Kato A, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, et al. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single‑center study. Ann Surg Oncol. 2013 Jan;20(1):318–324. https://doi.org/10.1245/s10434Test‑012‑2312‑8; Shroff RT, Javle MM, Xiao L, Kaseb AO, Varadhachary GR, Wolff RA, et al. Gemcitabine, Cisplatin, and nab‑Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial. JAMA Oncol. 2019 Jun 1;5(6):824–830. https://doi.org/10.1001/jamaoncol.2019.0270Test; Ray CE Jr, Edwards A, Smith MT, Leong S, Kondo K, Gipson M, et al. Metaanalysis of survival, complications, and imaging response following chemotherapy‑based transarterial therapy in patients with unresectable intrahepatic cholangiocarcinoma. J Vasc Interv Radiol. 2013 Aug;24(8):1218–1226. https://doi.org/10.1016/j.jvir.2013.03.019Test; Holster JJ, El Hassnaoui M, Franssen S, IJzermans JNM, de Jonge J, Mostert B, et al. Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta‑Analysis. Ann Surg Oncol. 2022 Sep;29(9):5528–5538. https://doi.org/10.1245/s10434Test‑022‑11439‑x; https://www.rpmj.ru/rpmj/article/view/860Test

  10. 30
    دورية أكاديمية